The expression of CCL8 in activated B-cell-like (ABC) DLBCL, a subtype with worse prognosis, was significantly lower than that in germinal-center B cell-like (GCB) DLBCL in GSE64555 (P < 0.05, Figure 7H). Here, CCL8 is linked to diffuse large B-cell lymphoma.